1. 65 yo M smoker, with GEJ adenocarcinoma undergoes chemoradiation with carboplatin -taxol per CROSS trial and then surgery.
Baseline pT3N1
Post treatment ypT2N0
What is the chance of recurrence- 70-75%
PFS without path CR 11 months
DFS with nivo 22 months
5-year relative survival rates for esophageal cancer
These numbers are based on people diagnosed with esophageal cancer between 2009 and 2015.
Stage | 5-Year Relative Survival Rate |
Localized | 47% |
Regional | 25% |
Distant | 5% |
All SEER stages combined | 20% |
